- Home
- INBX vs LANV Comparison
INBX vs LANV Comparison
Compare INBX & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- LANV
- Stock Information
- Founded
- INBX 2010
- LANV 2015
- Country
- INBX United States
- LANV China
- Employees
- INBX N/A
- LANV N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- LANV Blank Checks
- Sector
- INBX Health Care
- LANV Finance
- Exchange
- INBX Nasdaq
- LANV Nasdaq
- Market Cap
- INBX 222.5M
- LANV 196.8M
- IPO Year
- INBX 2020
- LANV N/A
- Fundamental
- Price
- INBX $13.98
- LANV $1.56
- Analyst Decision
- INBX Hold
- LANV
- Analyst Count
- INBX 1
- LANV 0
- Target Price
- INBX N/A
- LANV N/A
- AVG Volume (30 Days)
- INBX 70.4K
- LANV 23.6K
- Earning Date
- INBX 11-14-2024
- LANV 08-26-2024
- Dividend Yield
- INBX N/A
- LANV N/A
- EPS Growth
- INBX N/A
- LANV N/A
- EPS
- INBX 119.38
- LANV N/A
- Revenue
- INBX $1,568,000.00
- LANV $409,961,427.00
- Revenue This Year
- INBX N/A
- LANV N/A
- Revenue Next Year
- INBX N/A
- LANV $11.31
- P/E Ratio
- INBX $0.12
- LANV N/A
- Revenue Growth
- INBX 19.24
- LANV N/A
- 52 Week Low
- INBX $10.80
- LANV $0.91
- 52 Week High
- INBX $18.95
- LANV $3.99
- Technical
- Relative Strength Index (RSI)
- INBX 37.51
- LANV 46.57
- Support Level
- INBX $13.27
- LANV $1.53
- Resistance Level
- INBX $14.49
- LANV $1.69
- Average True Range (ATR)
- INBX 1.00
- LANV 0.13
- MACD
- INBX -0.23
- LANV -0.00
- Stochastic Oscillator
- INBX 33.53
- LANV 48.39
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.